ArticleInternational journal of chronic obstructive pulmonary disease2025

Phase 2a, Randomized Trial of Mitiperstat Versus Placebo in Patients with COPD at High Risk of Exacerbation (CRESCENDO).

Rod Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.